It’s estimated that 90% of retail investors lose money. We help you beat those odds with concise research, education and more. Click here to see our offerings.
- A commercial-stage specialty pharmaceutical company focused on developing and commercializing self-administered injectable products leveraging its advanced auto-injector technology.
- Its product portfolio consists of three medications:
- Otrexup= the first FDA approved subcutaneous methotrexate autoinjector
- XYOSTED= the first and only weekly Testosterone therapy
- Sumatriptan= the generic equivalent to Imitrex (migraine/cluster headache treatment)
- ATRS’s pipeline has a number of proprietary and partnered products
- Partners include big pharma names like Teva, Pfizer, and Amag Pharmaceuticals